Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Profit before tax | -27.95 | -25.94 | 63.25 | 230.27 | 159.36 |
| Net cashflow-operating activity | -36.68 | -103.43 | -12.01 | 104.77 | 146.94 |
| Net cash used in investing activity | 2.41 | 101.37 | 3.20 | -37.81 | -352.64 |
| Netcash used in fin. activity | 34.86 | 2.75 | 4.55 | -52.05 | -30.00 |
| Net inc/dec in cash and equivlnt | 0.58 | 0.69 | -4.27 | 14.92 | -235.71 |
| Cash and equivalnt begin of year | 0.71 | 0.01 | 4.28 | 4.14 | 239.85 |
| Cash and equivalnt end of year | 1.29 | 0.71 | 0.01 | 19.06 | 4.14 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis